Longueuil, Quebec, Canada – MENODYS is proud to announce that the Beta prototype of the Sterile Saline Slush Making Apparatus (SSSMA) was used for the 50th time in an operating procedure at the Sacré-Coeur Hospital Organ Collection Center in Montreal, Quebec, Canada. The SSSMA enables the automated production of large volumes of sterile saline slush needed for the preservation of human organs.

Invented by Dr Pierre Marsolais, internal medicine specialist, intensivist and coordinator of the Organ Collection Center of the Sacré-Coeur Hospital of Montreal, this patent pending medical technology, developed jointly with MENODYS, has been designed as a module to automate the transformation of 1 litre bags (up to 9 liters at a time in the Beta prototype) of sterile saline into slush to be used in organ collection and transplant procedures.

“ The fact that the SSSMA Beta prototype has been performing its objective of automating the production of large volume of sterile saline slush to be used in organ collection and transplant procedures for more than 16 months in a real-life setting proves that the technology design and conception is working as planned” said René Gosselin, President of MENODYS. “The benefits of having access to an automated technology for the production of large volumes a sterile saline slush has had a tremendous positive impact on the workload and planning of the Sacré-Coeur Hospital Organ Collection Centre staff” said Dr Pierre Marsolais.

MENODYS is also announcing the signature with Univalor, the Office of Technology Transfer of the University of Montreal, of an exclusive worldwide technology licence agreement on the commercial rights to the SSSMA technology.

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com